Krabbe Disease Treatment Market 2027 by Type, Application | The Insight Partners

Krabbe Disease Treatment Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type (Anticonvulsants, Muscle Relaxants, HSCT, Others); Application (Hospitals, ASCs)

Report Code: TIPRE00008179 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Krabbe disease is a rare and frequently deadly disorder of the nervous system, and it is an inherited genetic disease. People suffering from Krabbe disease are not able to create enough of a substance called galactosylceramidase, which is needed to make myelin.

MARKET DYNAMICS

The Krabbe disease treatment market is expected to grow significantly due to special drug designations and biologics that are intended for the safe and effective treatment of the disease. However, a limited patient pool for clinical trials is restraining market growth. Moreover, the introduction of gene technology is in the development of therapeutics for Krabbe disease is expected to benefit the growth of the market in the forecast period.

MARKET SCOPE

The "Krabbe Disease Treatment Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in krabbe disease treatment market with detailed market segmentation by type, application and geography. The krabbe disease treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in krabbe disease treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The krabbe disease treatment market is segmented on the basis of type and application. Based on type the market is segmented as anticonvulsants, muscle relaxants, HSCT and others. On the basis of application the market is categorized as hospitals and ASCs.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in krabbe disease treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The krabbe disease treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting krabbe disease treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the krabbe disease treatment market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in krabbe disease treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in krabbe disease treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for in krabbe disease treatment market in the global market. Below mentioned is the list of few companies engaged in the krabbe disease treatment market.

The report also includes the profiles of key in krabbe disease treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Abbott Laboratories
  •  CENTOGENE N.V.
  •  GlaxoSmithKline plc
  •  Johnson & Johnson Services, Inc
  •  Novartis AG
  •  Pfizer Inc.
  •  Sanofi-Aventis SA
  •  Shire
  •  Teva Pharmaceutical Industries Ltd.
  •  UCB Pharmaceuticals

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Krabbe Disease Treatment Market - By Type
1.3.2 Krabbe Disease Treatment Market - By Application
1.3.3 Krabbe Disease Treatment Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. KRABBE DISEASE TREATMENT MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. KRABBE DISEASE TREATMENT MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. KRABBE DISEASE TREATMENT MARKET - GLOBAL MARKET ANALYSIS

6.1. KRABBE DISEASE TREATMENT - GLOBAL MARKET OVERVIEW
6.2. KRABBE DISEASE TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. KRABBE DISEASE TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TYPE

7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTICONVULSANTS
7.3.1. Overview
7.3.2. Anticonvulsants Market Forecast and Analysis
7.4. MUSCLE RELAXANTS
7.4.1. Overview
7.4.2. Muscle Relaxants Market Forecast and Analysis
7.5. HSCT
7.5.1. Overview
7.5.2. HSCT Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis

8. KRABBE DISEASE TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION

8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. ASCS
8.4.1. Overview
8.4.2. ASCs Market Forecast and Analysis

9. KRABBE DISEASE TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
9.1.1 North America Krabbe Disease Treatment Market Overview
9.1.2 North America Krabbe Disease Treatment Market Forecasts and Analysis
9.1.3 North America Krabbe Disease Treatment Market Forecasts and Analysis - By Type
9.1.4 North America Krabbe Disease Treatment Market Forecasts and Analysis - By Application
9.1.5 North America Krabbe Disease Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Krabbe Disease Treatment Market
9.1.5.1.1 United States Krabbe Disease Treatment Market by Type
9.1.5.1.2 United States Krabbe Disease Treatment Market by Application
9.1.5.2 Canada Krabbe Disease Treatment Market
9.1.5.2.1 Canada Krabbe Disease Treatment Market by Type
9.1.5.2.2 Canada Krabbe Disease Treatment Market by Application
9.1.5.3 Mexico Krabbe Disease Treatment Market
9.1.5.3.1 Mexico Krabbe Disease Treatment Market by Type
9.1.5.3.2 Mexico Krabbe Disease Treatment Market by Application
9.2. EUROPE
9.2.1 Europe Krabbe Disease Treatment Market Overview
9.2.2 Europe Krabbe Disease Treatment Market Forecasts and Analysis
9.2.3 Europe Krabbe Disease Treatment Market Forecasts and Analysis - By Type
9.2.4 Europe Krabbe Disease Treatment Market Forecasts and Analysis - By Application
9.2.5 Europe Krabbe Disease Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Krabbe Disease Treatment Market
9.2.5.1.1 Germany Krabbe Disease Treatment Market by Type
9.2.5.1.2 Germany Krabbe Disease Treatment Market by Application
9.2.5.2 France Krabbe Disease Treatment Market
9.2.5.2.1 France Krabbe Disease Treatment Market by Type
9.2.5.2.2 France Krabbe Disease Treatment Market by Application
9.2.5.3 Italy Krabbe Disease Treatment Market
9.2.5.3.1 Italy Krabbe Disease Treatment Market by Type
9.2.5.3.2 Italy Krabbe Disease Treatment Market by Application
9.2.5.4 Spain Krabbe Disease Treatment Market
9.2.5.4.1 Spain Krabbe Disease Treatment Market by Type
9.2.5.4.2 Spain Krabbe Disease Treatment Market by Application
9.2.5.5 United Kingdom Krabbe Disease Treatment Market
9.2.5.5.1 United Kingdom Krabbe Disease Treatment Market by Type
9.2.5.5.2 United Kingdom Krabbe Disease Treatment Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Krabbe Disease Treatment Market Overview
9.3.2 Asia-Pacific Krabbe Disease Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Krabbe Disease Treatment Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Krabbe Disease Treatment Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Krabbe Disease Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Krabbe Disease Treatment Market
9.3.5.1.1 Australia Krabbe Disease Treatment Market by Type
9.3.5.1.2 Australia Krabbe Disease Treatment Market by Application
9.3.5.2 China Krabbe Disease Treatment Market
9.3.5.2.1 China Krabbe Disease Treatment Market by Type
9.3.5.2.2 China Krabbe Disease Treatment Market by Application
9.3.5.3 India Krabbe Disease Treatment Market
9.3.5.3.1 India Krabbe Disease Treatment Market by Type
9.3.5.3.2 India Krabbe Disease Treatment Market by Application
9.3.5.4 Japan Krabbe Disease Treatment Market
9.3.5.4.1 Japan Krabbe Disease Treatment Market by Type
9.3.5.4.2 Japan Krabbe Disease Treatment Market by Application
9.3.5.5 South Korea Krabbe Disease Treatment Market
9.3.5.5.1 South Korea Krabbe Disease Treatment Market by Type
9.3.5.5.2 South Korea Krabbe Disease Treatment Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Krabbe Disease Treatment Market Overview
9.4.2 Middle East and Africa Krabbe Disease Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Krabbe Disease Treatment Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Krabbe Disease Treatment Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Krabbe Disease Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Krabbe Disease Treatment Market
9.4.5.1.1 South Africa Krabbe Disease Treatment Market by Type
9.4.5.1.2 South Africa Krabbe Disease Treatment Market by Application
9.4.5.2 Saudi Arabia Krabbe Disease Treatment Market
9.4.5.2.1 Saudi Arabia Krabbe Disease Treatment Market by Type
9.4.5.2.2 Saudi Arabia Krabbe Disease Treatment Market by Application
9.4.5.3 U.A.E Krabbe Disease Treatment Market
9.4.5.3.1 U.A.E Krabbe Disease Treatment Market by Type
9.4.5.3.2 U.A.E Krabbe Disease Treatment Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Krabbe Disease Treatment Market Overview
9.5.2 South and Central America Krabbe Disease Treatment Market Forecasts and Analysis
9.5.3 South and Central America Krabbe Disease Treatment Market Forecasts and Analysis - By Type
9.5.4 South and Central America Krabbe Disease Treatment Market Forecasts and Analysis - By Application
9.5.5 South and Central America Krabbe Disease Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Krabbe Disease Treatment Market
9.5.5.1.1 Brazil Krabbe Disease Treatment Market by Type
9.5.5.1.2 Brazil Krabbe Disease Treatment Market by Application
9.5.5.2 Argentina Krabbe Disease Treatment Market
9.5.5.2.1 Argentina Krabbe Disease Treatment Market by Type
9.5.5.2.2 Argentina Krabbe Disease Treatment Market by Application

10. INDUSTRY LANDSCAPE

10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. KRABBE DISEASE TREATMENT MARKET, KEY COMPANY PROFILES

11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. CENTOGENE N.V.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GLAXOSMITHKLINE PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. JOHNSON AND JOHNSON SERVICES, INC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. NOVARTIS AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PFIZER INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SANOFI-AVENTIS SA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SHIRE
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. UCB PHARMACEUTICALS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. CENTOGENE N.V.
3. GlaxoSmithKline plc
4. Johnson & Johnson Services, Inc
5. Novartis AG
6. Pfizer Inc.
7. Sanofi-Aventis SA
8. Shire
9. Teva Pharmaceutical Industries Ltd.
10. UCB Pharmaceuticals
TIPRE00008179
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking